This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignees: Massachusetts Institute of Technology, Whitehead Institute for Biomedical Research. Active years: 2020-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 8,586 
2 out of 318 
Years Active: 2020-2025
Title: Innovations of Jasdave S Chahal
Introduction
Jasdave S Chahal is an accomplished inventor based in Arlington, MA (US). He has made significant contributions to the field of biomedical research, particularly in the development of modified dendrimer nanoparticles for therapeutic applications. With a total of 2 patents, his work has the potential to impact various medical treatments.
Latest Patents
Chahal's latest patents focus on "Compositions and methods for modified dendrimer nanoparticle delivery." These innovations involve the delivery of therapeutic, prophylactic, and diagnostic agents, such as large repRNA molecules, to the cells of a subject. The modified dendrimer nanoparticles (MDNPs) are designed to efficiently drive the proliferation of antigen-specific T cells against intracellular antigens and enhance antigen-specific antibody responses. Furthermore, MDNPs can be multiplexed to deliver multiple different repRNAs, allowing for the modification of expression kinetics of encoded antigens. This technology also enables the simultaneous delivery of repRNAs and mRNAs that include the same UTR elements, promoting the expression of encoded antigens.
Career Highlights
Throughout his career, Jasdave S Chahal has worked with prestigious institutions, including the Massachusetts Institute of Technology and the Whitehead Institute for Biomedical Research. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Chahal has collaborated with notable coworkers, including Omar Khan and Daniel Griffith Anderson. These partnerships have further enriched his research and development efforts in the biomedical sector.
Conclusion
Jasdave S Chahal's innovative work in the field of modified dendrimer nanoparticles showcases his dedication to advancing medical science. His patents and collaborations reflect a commitment to improving therapeutic delivery systems, which could lead to significant advancements in patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile